MDAIW · Spectral AI, Inc. · Webcasts, Transcripts & Audio
Market Cap
$48.28M
Shares
32.18M
Volume · Oct 23
9664
Avg daily vol (3M)
7214
Spectral AI, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Spectral AI, Inc. (MDAIW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-12
Spectral AI, Inc. (MDAIW) Q2 2026 Earnings Call Transcript
Confident tone
Commercial launch and U.S. deployment under BARDA
FDA de novo clearance / DeepView system regulatory milestone
International expansion (UK, Australia, GCC)
Revenue
$3.52M
▼ 30.4% YoY Diluted EPS
$-0.13
Gross margin
31.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
Spectral AI, Inc. (MDAIW) Q1 2026 Earnings Call Transcript
Confident tone
FDA De Novo Submission and Timeline
DeepView / DPU System Commercialization
Clinical Studies and ABA Conference
Revenue
$3.99M
▼ 40.5% YoY Diluted EPS
$-0.11
▼ 200% YoY Gross margin
50.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Spectral AI, Inc. (MDAIW) Q4 2025 Earnings Call Transcript
Confident tone
BARDA Contract and Funding
DeepView System Commercialization
FDA De Novo Submission and Approval
Revenue
$4.09M*
▼ 46.3% YoY Gross margin
45.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-11
Spectral AI, Inc. (MDAIW) Q3 2025 Earnings Call Transcript
Positive tone
BARDA Project BioShield contract
DeepView system commercialization
Handheld device and military applications
Revenue
$3.79M
▼ 53.6% YoY Diluted EPS
$-0.13
Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Spectral AI, Inc. (MDAIW) Q2 2025 Earnings Call Transcript
Positive tone
FDA submission / DeepView de novo clearance
Handheld / Snapshot device
Revenue and financial performance
Revenue
$5.07M
▼ 32.3% YoY Diluted EPS
$-0.31
Gross margin
45.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Spectral AI, Inc. (MDAIW) Q1 2025 Earnings Call Transcript
Confident tone
Burn Validation Study
FDA De Novo Submission
BARDA Project BioShield Contract
Revenue
$6.71M
▲ 6% YoY Diluted EPS
$0.11
Gross margin
47.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Spectral AI, Inc. (MDAIW) Q3 2024 Earnings Call Transcript
Confident tone
Leadership Renewal and 3 Fs Framework
UK and Australia International Expansion
BARDA Contract and Government Funding
Revenue
$8.17M
▲ 137.6% YoY Diluted EPS
$-0.08
Gross margin
44.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Spectral AI, Inc. (MDAIW) Q2 2024 Earnings Call Transcript
Confident tone
Commercialization of DeepView in the UK
Pivotal study enrollment
Geographic expansion and partnerships
Revenue
$7.48M
▲ 75.9% YoY Diluted EPS
$-0.16
Gross margin
44.3%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Spectral AI, Inc. (MDAIW) Q1 2024 Earnings Call Transcript
Confident tone
BARDA Project BioShield contract
Clinical studies (burn pivotal and DFU)
Spectral IP subsidiary / spin-off
Revenue
$6.33M
▲ 24.6% YoY Diluted EPS
$-0.19
Gross margin
46.6%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-29
Spectral AI, Inc. (MDAIW) Q4 2023 Earnings Call Transcript
Confident tone
DeepView Burn Indication Commercialization
U.S. Government / BARDA Contract (Project BioShield)
2024 Financial Outlook / Revenue Guidance
Revenue
$5.29M*
Gross margin
46.1%
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-14
Spectral AI, Inc. (MDAIW) Q3 2023 Earnings Call Transcript
Revenue
$3.44M
▼ 51.1% YoY Diluted EPS
$-0.77
Gross margin
42.8%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Showing 1–11 of 11 webcasts